Screening for genetic predisposition to mutagens in cancer patients

Experimental Gerontology

Volumn 31, Issue 1-2, 1996, Pages 267-280

  Gupta, Radhey S ^a   Gupta, Rajni ^a   Goldstein, Samuel ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

cancer predisposition; DNA repair disorders; ethidium bromide; mutagen sensitivity

Indexed keywords

BLEOMYCIN; CAMPTOTHECIN; DACTINOMYCIN; DNA; DNA TOPOISOMERASE; ETHIDIUM BROMIDE; MESYLIC ACID ETHYL ESTER; MESYLIC ACID METHYL ESTER; MITOMYCIN C; MUTAGENIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CHILD; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DRUG RESISTANCE; DRUG SENSITIVITY; FEMALE; FETUS; FIBROBLAST CULTURE; GENETIC PREDISPOSITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; SCREENING; SKIN BIOPSY;

EID: 0029875191     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/0531-5565(95)00023-2     Document Type: Article

References (33)

1. ARLETT, C.F., and LEHMANN, A.R. Human disorders showing increased sensitivity to the induction of genetic damage. Annu. Rev. Genet. 12, 95-115, 1978.
2. BUCHWALD, M. and INGLES, C.J. Human diploid fibroblast mutants with altered RNA polymerase, II. Somat. Cell Genet. 2, 225-233, 1976.
3. CLEAVER, J.E. and BOOTSMA, D. Xeroderma pigmentosum: Biochemical and genetic characteristics. Annu. Rev. Genet. 9, 19-38, 1975.
4. COOPER, J.T. and GOLDSTEIN, S. Skin biopsy and successful fibroblast culture. Lancet 1, 673, 1973.
5. CRISTOFALO, V.J. Animal cell cultures as a model system for the study of aging. Adv. Gerontol. Res. 4, 45-79, 1972.
6. DIGEWEED, M M. Human genetic instability syndromes: Single gene defects with increased risk of cancer. Toxicol. Lett. 67, 259-281, 1993.
7. FUJIWARA, Y., TATSUMI, M., and SASAKI, M.S. Crosslink repair in human cells and 16 possible defects in Fanconi's anemia cells. J. Mol. Biol. 133, 635-649, 1977.
8. GERMAN, J. Bloom's syndrome. II. The prototype of human genetic disorders predisposing to chromosome instability and cancer. In: Chromosomes and Cancer, German, J. (Editor), pp. 601-617, John Wiley & Sons, New York, 1974.
9. GOLDSTEIN, S. The role of DNA repair in aging of cultured fibroblasts from Xeroderma pigmentosum and normals. Proc. Soc. Exp. Biol. Med. 137, 730-734, 1971.
10. GOLDSTEIN, S. Human genetic disorders which feature accelerated aging. In: The Genetics of Aging, Schneider, E.L. (Editor), pp. 171-224, Plenum Press, New York, 1978.
11. 2 by normal and diabetic fibroblasts in culture. Diabetes 18, 545-549, 1969.
12. GUPTA, R.S. Senescence of cultured human diploid fibroblasts: Are mutations responsible. J. Cell. Physiol. 103, 209-216, 1980.
13. GUPTA, R.S. and GOLDSTEIN, S. Diphtheria toxic resistance in human fibroblast cell strains from normal and cancer-prone individuals. Mutat. Res. 73, 331-338, 1980.
14. GUPTA, R.S. and GOLDSTEIN, S. Mutagen testing in the human fibroblast diphtheria toxic resistance (HFDipr) system. In: Prog. Mut. Res. Short-Term Tests for Carcinogens, de Serres, F.J. and Ashby, J. (Editors), Vol. 1, pp. 614-625, Elsevier-North Holland, Amsterdam, 1981.
15. GUPTA, R.S. and GOLDSTEIN, S. Human fibroblast strains showing increased sensitivity or resistance to ethidium bromide. Mutat. Res. 105, 183-188, 1982.
16. HARNDEN, D.G. Genetic susceptibility to chemical carcinogens. In: Chemical Carcinogenesis and Mutagenesis, II. Handbook of Experimental Pharmacology, Cooper, C. and Grover, P.L. (Editors), Vol. 94/1, pp. 225-248, Springer-Verlag, Berlin, 1990.
17. HAYFLICK, L. The limited in vitro life-time of human diploid cell strains. Exp. Cell Res. 37, 614-636, 1965.
18. HEDDLE, J.A., KREPINSKI, A.B., and MARSHALL, R.R. Cellular sensitivity to mutagens and carcinogens in the chromosome-breakage and other cancer-prone systems. In: Chromosome Mutation and Neoplasia, German, J. (Editor), pp. 203-234, Alan R. Liss, New York, 1983.
19. JACOBS, J.P., JONES, C.M., and BAILLIE, J.P. Characteristics of a human diploid cell designated MRC-5. Nature 227, 168-170, 1970.
20. KNUDSON, A.G. Hereditary cancer, oncogenes and antioncogenes. Cancer Res. 45, 1437-1443, 1985.
21. LI, F.P. and MONTESANO, R. Interaction of cancer susceptibility genes and environmental carcinogens. Cancer Res. 54, 4243-4247, 1994.
22. MACIEIRA-COELHO, A. Contributions made by the studies of cells in vitro for understanding of the mechanisms of aging. Exp. Gerontol. 28, 1-16, 1993.
23. NEBERT, D.W. Role of genetics and drug metabolism in human cancer risk. Mutat. Res. 247, 267-281, 1991.
24. PATERSON, M.C. and SMITH, P.J. Ataxia telangiectasia: An inherited human disorder involving hyper-sensitivity to ionizing radiation and related DNA-damaging chemicals. Annu. Rev. Genet. 13, 291-318, 1979.
25. PETERSON, R.D.A., FUNKHOUSER, J.D., TUCK-MULLER, C.M., and GATTI, R.A. Cancer susceptibility in ataxia-telangiectasia. Leukemia 6, 8-13, 1992.
26. PIPPARD, E.C., HALL, A.J., BARKER, D.J., and BRIDGES, B.A. Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and Xeroderma pigmentosum in Britain. Cancer Res. 48, 2929-2932, 1988.
27. SASAKI, M.S. Fanconi's anemia: A condition possibly associated with a defective DNA repair. In: DNA Repair Mechanisms, Friedberg, E.C. and Fox, C.F. (Editors), pp. 675-684, Academic Press, New York, 1978.
28. SETLOW, R.B. Repair deficient human disorders and cancer. Nature 271, 713-717, 1978.
29. SINGER, B. and GRUNBERGER, D. Molecular Biology of Mutagens and Carcinogens, pp. 1-348, Plenum Press, New York, 1983.
30. SINGH. B. and GUPTA, R.S. Mutagenic responses of thirteen anticancer drugs on mutation induction at multiple genetic loci and on sister chromatid exchanges in Chinese hamster ovary cells. Cancer Res. 43, 577-584, 1983.
31. SWIFT, M., CHASE, C.L., and MORRELL, D. Cancer predisposition of ataxia-telangiectasia heterozygotes. Cancer Genet. Cytogenet. 46, 21-27, 1990.
32. SWIFT, M., REITNAUER, P.J., MORRELL, D., and CHASE, C.L. Breast and other cancers in ataxia-telangiectasia families. N. Engl. J. Med. 316, 1289-1294, 1987.
33. VENITT, S. Mechanism of carcinogenesis and individual susceptibility to cancer. Clin. Chem. 40, 1425-1425, 1994.